B of A Securities Rates Doximity (DOCS) sell, $20 Price Target
B of A Securities set a new sell rating and a $20 price target for Doximity, Inc, a 3.57% downside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
B of A Securities rated Doximity, Inc. ($DOCS) "sell" with a $20 price target on June 29, 2026.
Since the rating, $DOCS is up 11.0% after 1 week, up 5.0% after 1 month and up 50.4% to date (from the $20.59 close on Jun 29, 2026).
DOCS
Doximity, Inc.
Key Points
- On June 29, 2026, B of A Securities downgraded Doximity, Inc. (NYSE:DOCS) to a sell rating with a $20 price target.
- B of A Securities's $20 price target implies 3.57% downside from Doximity, Inc.'s ($DOCS) current $20.74 share price.
- Doximity shares traded at $20.88 on Monday, with a market cap of about $3.82 billion and a P/E ratio of 21.3.
- Insider activities included multiple transactions by Interim PAO Siddharth Sitaram, while analysts have mixed ratings on the stock.
Get $DOCS trade alerts by text
We text you when insiders, Congress or big funds trade $DOCS. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Doximity, Inc. alert may contain errors. Disclosures
On June 29, 2026, B of A Securities analyst Allen Lutz downgraded Doximity, Inc. (NYSE:DOCS) to a sell rating, setting a new price target of $20. This change comes as the stock traded around $20.88 on Monday.
B of A Securities vs. the S&P 500
Hypothetical returns from B of A Securities's disclosed trades, not real profit or advice. How we model this.
Doximity, Inc. Stock Down 34.2%
Shares of NYSE:DOCS traded near $20.88 on Monday. Doximity, Inc. has a market cap of approximately $3.82 billion, a P/E ratio of 21.3, and a forward P/E of 13.1. The stock has seen a 52-week low of $17.15 and a high of $76.51. Its 50-day moving average is $22.11, while the 200-day moving average stands at $39.57. The company's financial health is reflected in its current ratio of 6.09 and a quick ratio of 5.81.
$DOCS price target
Doximity, Inc. daily closes and this analyst's $20 target. Not advice.
Recent Earnings
Doximity reported revenue of $644.9 million, growing by 5.1% year-over-year. The net margin stands at 30.4%, with a return on equity of 19.3%. The next earnings report is expected on August 6, 2026.
Insider Buying and Selling at Doximity, Inc.
Insider transactions at Doximity included several by Interim PAO Siddharth Sitaram on June 8, 2026. Sitaram both bought and sold 5,000 shares on that day, with some transactions planned under Rule 10b5-1. President Steven Zatz also acquired 55,524 shares on May 15, 2026.
Analysts Set New Price Targets
On June 29, 2026, B of A Securities downgraded Doximity to a sell rating with a $20 price target. Previously, Barclays downgraded the stock to hold with the same target on May 15, 2026. Leerink Partners maintained a buy rating with a $25 target on May 14, 2026. The consensus among 19 analysts is a buy rating, with a mean target price of $25.32.
About Doximity, Inc.
Doximity, Inc., headquartered in San Francisco, operates a digital platform for medical professionals in the U.S. The platform provides a personalized newsfeed with clinical and professional content and offers tools like a HIPAA-compliant AI assistant and telehealth services. Led by CEO Jeffrey A. Tangney, the company serves healthcare providers and systems.
Bottom Line
B of A Securities' downgrade to a sell rating for Doximity, Inc. reflects a cautious outlook with a new price target of $20. Investors keep a close eye on analyst ratings and insider activities for indications of company health. It's important to remember that analyst ratings and price targets are subject to change and should be considered as part of a broader investment strategy.
Related Filing Alerts
Source: B of A Securities's rating change on $DOCS (Jun 29, 2026). Written by software, not financial advice. How we make alerts